(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 18.84%28.31B | 22.01%18.34B | 25.29%8.84B | 18.02%33.16B | 16.56%23.83B | 16.49%15.03B | 7.71%7.05B | 19.05%28.1B | 19.16%20.44B | 11.79%12.9B |
Operating income | 18.84%28.31B | 22.01%18.34B | 25.29%8.84B | 18.02%33.16B | 16.56%23.83B | 16.49%15.03B | 7.71%7.05B | 19.05%28.1B | 19.16%20.44B | 11.79%12.9B |
Cost of sales | ---- | -16.20%-11.64B | ---- | -15.55%-21.84B | ---- | -16.54%-10.02B | ---- | -23.11%-18.9B | ---- | -16.63%-8.59B |
Operating expenses | -13.59%-17.61B | -16.20%-11.64B | -18.49%-5.58B | -15.55%-21.84B | -15.74%-15.5B | -16.54%-10.02B | -11.99%-4.71B | -23.11%-18.9B | -23.09%-13.39B | -16.63%-8.59B |
Gross profit | 28.61%10.71B | 33.61%6.7B | 38.96%3.25B | 23.08%11.32B | 18.12%8.33B | 16.38%5.01B | 0.01%2.34B | 11.48%9.2B | 12.35%7.05B | 3.23%4.31B |
Selling expenses | -11.72%-1.22B | -15.83%-785.62M | -14.05%-387.66M | -13.92%-1.54B | -13.33%-1.09B | -10.25%-678.25M | -15.04%-339.9M | -17.35%-1.35B | -15.62%-960.81M | -11.24%-615.22M |
Administrative expenses | -17.82%-2.08B | -17.91%-1.35B | -30.25%-710.2M | -15.87%-2.49B | -14.23%-1.77B | -14.07%-1.14B | -9.45%-545.27M | -10.16%-2.15B | -9.99%-1.55B | -6.88%-1B |
Research and development expenses | -22.90%-1.21B | -24.78%-784.11M | -24.84%-375.9M | -12.37%-1.4B | -10.95%-988.3M | -12.72%-628.38M | -11.06%-301.11M | -25.21%-1.25B | -23.76%-890.75M | -18.09%-557.46M |
Profit from asset sales | 928.21%8.8M | ---- | 1,416.91%5.47M | ---- | 112.57%855.87K | ---- | 32.32%360.42K | ---- | -717.13%-6.81M | ---- |
Revaluation surplus | 64.25%-443.85K | ---- | -13.51%-926.12K | ---- | 95.48%-1.24M | ---- | 60.91%-815.89K | ---- | -218.25%-27.46M | ---- |
-Changes in the fair value of other assets | 64.25%-443.85K | ---- | -13.51%-926.12K | ---- | 95.48%-1.24M | ---- | 60.91%-815.89K | ---- | -218.25%-27.46M | ---- |
Impairment and provision | 91.68%-3.91M | 198.47%7.74M | 451.83%5.57M | -318.03%-17.11M | -1,680.71%-46.95M | -816.77%-7.86M | -248.67%-1.58M | 24.71%-4.09M | 55.71%-2.64M | 462.05%1.1M |
-Other impairment is provision | 91.68%-3.91M | 198.47%7.74M | 451.83%5.57M | -318.03%-17.11M | -1,680.71%-46.95M | -816.77%-7.86M | -248.67%-1.58M | 24.71%-4.09M | 55.71%-2.64M | 462.05%1.1M |
Special items of operating profit | -60.08%51.64M | -102.96%-18.37M | -288.17%-94.32M | -55.21%510.89M | -12.03%129.37M | 5.62%621.38M | 44.84%50.13M | 665.28%1.14B | -35.54%147.06M | 985.45%588.32M |
Operating profit | 38.02%6.04B | 18.68%3.77B | 41.95%1.64B | 14.26%6.38B | 21.88%4.38B | 16.70%3.18B | -8.09%1.15B | 41.65%5.58B | 6.29%3.59B | 27.01%2.72B |
Financing income | ---- | 80.63%510.16M | ---- | 133.70%614M | ---- | 215.68%282.43M | ---- | 55.61%262.73M | ---- | 6.22%89.47M |
Financing cost | -19.86%451.39M | -7.62%-158.66M | 323.53%69.31M | -0.07%-288.32M | -43.40%563.25M | 6.66%-147.43M | 82.72%-31.01M | 9.66%-288.12M | 401.46%995.23M | 0.57%-157.95M |
Share of profits of associates | ---- | ---- | ---- | -48.49%10.8M | ---- | ---- | ---- | -22.29%20.96M | ---- | ---- |
Share of profit from joint venture company | ---- | -66.50%2.25M | ---- | ---- | ---- | -54.00%6.72M | ---- | ---- | ---- | 133.73%14.61M |
Special items of earning before tax | 34.39%-30.97M | ---- | -35.33%-10.95M | ---- | -348.38%-47.19M | ---- | 2.63%-8.09M | ---- | -158.86%-10.53M | ---- |
Earning before tax | 32.06%6.46B | 24.27%4.13B | 52.17%1.69B | 20.38%6.72B | 6.93%4.89B | 24.36%3.32B | 4.43%1.11B | 46.10%5.58B | 49.20%4.58B | 28.60%2.67B |
Tax | -27.85%-981.16M | -29.02%-623.52M | -53.78%-306.28M | -31.54%-1.09B | -13.03%-767.46M | -67.24%-483.27M | -1.65%-199.17M | -22.26%-826.31M | -42.90%-678.96M | 6.45%-288.97M |
After-tax profit from continuing operations | 32.84%5.48B | 23.46%3.5B | 51.82%1.39B | 18.44%5.63B | 5.87%4.13B | 19.16%2.84B | 5.06%914.44M | 51.23%4.75B | 50.36%3.9B | 34.73%2.38B |
Earning after tax | 32.84%5.48B | 23.46%3.5B | 51.82%1.39B | 18.44%5.63B | 5.87%4.13B | 19.16%2.84B | 5.06%914.44M | 51.23%4.75B | 50.36%3.9B | 34.73%2.38B |
Minority profit | 176.70%4.24M | 906.54%3.23M | 848.40%499.71K | 94.71%-148K | 168.31%1.53M | 123.24%321K | 91.51%-66.77K | 12.12%-2.8M | 23.13%-2.24M | 38.35%-1.38M |
Profit attributable to shareholders | 32.79%5.48B | 23.36%3.5B | 51.76%1.39B | 18.37%5.63B | 5.77%4.13B | 19.08%2.84B | 4.97%914.51M | 51.16%4.76B | 50.28%3.9B | 34.63%2.38B |
Basic earnings per share | 32.91%2.1 | 22.94%1.34 | 51.43%0.53 | 18.68%2.16 | 6.04%1.58 | 19.78%1.09 | 6.06%0.35 | 47.97%1.82 | 46.08%1.49 | 30.00%0.91 |
Diluted earnings per share | 32.91%2.1 | 22.94%1.34 | 51.43%0.53 | 18.68%2.16 | 6.04%1.58 | 19.78%1.09 | 6.06%0.35 | 47.97%1.82 | 46.08%1.49 | 30.00%0.91 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data